HealthCare Global Enterprises (NSE:HCG) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:HCG HealthCare Global Enterprises Ltd NSE:HCG
83 GF Score
Price ₹655.85
GF Value ₹580.90
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is HealthCare Global Enterprises FFO?

FFO (Funds from operations) only applies to REITs.

NSE:HCG
83GF Score
HealthCare Global Enterprises Ltd NSE:HCG
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?

Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued. The current stock price of ₹655.85 is trading 12.9% above its estimated GF Value™ of ₹580.90. GuruFocus considers HealthCare Global Enterprises to be Modestly Overvalued.

Key valuation signals for NSE:HCG:

  • FFO:
  • GF Value™: ₹580.90 vs. price of ₹655.85 (12.9% above fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HealthCare Global Enterprises Business Description

Other Exchanges 539787:India
Address Mission Road, No. 3, Ground Floor, Tower Block, Unity Building Complex, Bengaluru, KA, IND, 560027
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
83GF Score

Get the complete analysis for NSE:HCG

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹655.85
Price
₹580.90
GF Value